Literature DB >> 20424928

Incidence of benign disease in patients that underwent resection for presumed pancreatic cancer diagnosed by endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA).

Sebastian G de la Fuente1, Eugene P Ceppa, Srinevas K Reddy, Bryan M Clary, Douglas S Tyler, Theodore N Pappas.   

Abstract

INTRODUCTION: The lack of accurate markers makes preoperative differentiation between pancreatic cancer and non-malignant head lesions clinically challenging. In this study, we investigated the incidence of benign disease in patients that underwent resection for presumed pancreatic cancer diagnosed by EUS and EUS-guided FNA.
METHODS: Medical records of consecutive patients who underwent pancreaticoduodenectomy at Duke University were reviewed. Demographics, clinicopathologic characteristics, preoperative imaging, EUS, EUS-guided FNA, and postoperative outcomes were analyzed.
RESULTS: Seven percent of the total 494 patients studied were found to have benign disease on postoperative pathology. Fifty-nine percent of these patients with benign disease underwent preoperative EUS. EUS was positive for a head mass in 70%, demonstrated enlarged lymph nodes in 27%, and showed signs concerning for vascular invasion in 13%. FNA was suspicious or indeterminate for cancer in 63% of patients. Postoperative complications occurred in 47% and one patient died after surgery. The overall pancreatic leak rate was 15%.
CONCLUSIONS: Even with aggressive use of preoperative evaluation, there is still a small subset of patients where malignancy cannot be excluded without pancreaticoduodenectomy.

Entities:  

Mesh:

Year:  2010        PMID: 20424928     DOI: 10.1007/s11605-010-1196-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  31 in total

Review 1.  Endoscopic ultrasonography.

Authors:  M S Bhutani
Journal:  Endoscopy       Date:  2000-11       Impact factor: 10.093

2.  Influence of EUS training and pathology interpretation on accuracy of EUS-guided fine needle aspiration of pancreatic masses.

Authors:  Gavin C Harewood; Lisa M Wiersema; Amy C Halling; Gary L Keeney; Diva R Salamao; Maurits J Wiersema
Journal:  Gastrointest Endosc       Date:  2002-05       Impact factor: 9.427

3.  Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas.

Authors:  K Kawaguchi; M Koike; K Tsuruta; A Okamoto; I Tabata; N Fujita
Journal:  Hum Pathol       Date:  1991-04       Impact factor: 3.466

Review 4.  Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review.

Authors:  John Dewitt; Benedict M Devereaux; Glen A Lehman; Stuart Sherman; Thomas F Imperiale
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-03       Impact factor: 11.382

5.  The characteristic appearance of non-alcoholic duct destructive chronic pancreatitis: a report of 2 cases.

Authors:  K A Scully; S C Li; J C Hebert; T D Trainer
Journal:  Arch Pathol Lab Med       Date:  2000-10       Impact factor: 5.534

6.  Eosinophilic pancreatitis mimicking pancreatic neoplasia: EUS and ERCP findings--is nonsurgical diagnosis possible?

Authors:  M Barthet; P Hastier; M J Buckley; J P Bernard; B Sastre; J L Baroni; J Salducci; J Delmont
Journal:  Pancreas       Date:  1998-11       Impact factor: 3.327

7.  Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT.

Authors:  Naoki Takahashi; Joel G Fletcher; David M Hough; Jeff L Fidler; Akira Kawashima; Jayawant N Mandrekar; Suresh T Chari
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

8.  Endoscopic ultrasound approach of pancreatic cancer in chronic pancreatitis patients in a tertiary referral centre.

Authors:  Sevasti Iordache; Adrian Săftoiu; Sergiu Cazacu; Dan Ionut Gheonea; Daniela Dumitrescu; Carmen Popescu; Tudorel Ciurea
Journal:  J Gastrointestin Liver Dis       Date:  2008-09       Impact factor: 2.008

9.  Radical pancreatoduodenectomy for misdiagnosed pancreatic mass.

Authors:  C D Smith; K E Behrns; J A van Heerden; M G Sarr
Journal:  Br J Surg       Date:  1994-04       Impact factor: 6.939

Review 10.  Staging of pancreatic cancer. Analysis of literature results.

Authors:  T Rösch
Journal:  Gastrointest Endosc Clin N Am       Date:  1995-10
View more
  11 in total

1.  Endoscopic ultrasound-guided fine-needle aspiration for suspected malignancies adjacent to the gastrointestinal tract.

Authors:  Pietro Gambitta; Antonio Armellino; Edoardo Forti; Maurizio Vertemati; Paola Enrica Colombo; Paolo Aseni
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma.

Authors:  Marianne J van Heerde; J Buijs; B E Hansen; M de Waart; C H J van Eijck; G Kazemier; C J Pek; J W Poley; M J Bruno; E J Kuipers; H R van Buuren
Journal:  Dig Dis Sci       Date:  2014-01-03       Impact factor: 3.199

Review 3.  A practical approach to the diagnosis of autoimmune pancreatitis.

Authors:  Luca Frulloni; Antonio Amodio; Anna Maria Katsotourchi; Italo Vantini
Journal:  World J Gastroenterol       Date:  2011-04-28       Impact factor: 5.742

4.  Unexpected benign histopathology after pancreatoduodenectomy for presumed malignancy: accepting the inevitable.

Authors:  Rachel M Gomes; Munita Bal; Shraddha Patkar; Mahesh Goel; Shailesh V Shrikhande
Journal:  Langenbecks Arch Surg       Date:  2016-01-26       Impact factor: 3.445

5.  Left-sided pancreatic incidentalomas treated with laparoscopic approach: a report of 20 cases.

Authors:  Marco Chiarelli; Martino Gerosa; Fulvio Tagliabue; Luca Fumagalli; Angelo Guttadauro; Francesco Gabrielli; Alessandro Marando; Matilde De Simone; Ugo Cioffi
Journal:  World J Surg Oncol       Date:  2016-08-04       Impact factor: 2.754

6.  Autoimmune pancreatitis: Imaging features.

Authors:  Yi Dong; Mirko D'Onofrio; Michael Hocke; Christian Jenssen; Andrej Potthoff; Nathan Atkinson; Andre Ignee; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

Review 7.  Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer.

Authors:  Takeichi Yoshida; Yasunobu Yamashita; Masayuki Kitano
Journal:  Diagnostics (Basel)       Date:  2019-07-24

8.  Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head.

Authors:  M J van Heerde; K Biermann; P E Zondervan; G Kazemier; C H J van Eijck; C Pek; E J Kuipers; H R van Buuren
Journal:  Dig Dis Sci       Date:  2012-05-16       Impact factor: 3.199

9.  Increased Incidence of Benign Pancreatic Pathology following Pancreaticoduodenectomy for Presumed Malignancy over 10 Years despite Increased Use of Endoscopic Ultrasound.

Authors:  Shadi S Yarandi; Thomas Runge; Lei Wang; Zhijian Liu; Yueping Jiang; Saurabh Chawla; Kevin E Woods; Steven Keilin; Field F Willingham; Hong Xu; Qiang Cai
Journal:  Diagn Ther Endosc       Date:  2014-06-05

Review 10.  Endoscopic ultrasound (EUS) and the management of pancreatic cancer.

Authors:  Muhammad Nadeem Yousaf; Fizah S Chaudhary; Amrat Ehsan; Alejandro L Suarez; Thiruvengadam Muniraj; Priya Jamidar; Harry R Aslanian; James J Farrell
Journal:  BMJ Open Gastroenterol       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.